Bird & Bird has advised Gaussion. Osborne Clarke has acted for AlbionVC and UCL Technology Fund Gaussion has completed a $28 million funding round, bringing its...
Gaussion Secures $28 Million in Funding to Accelerate Battery Innovation
Flok Health Secures $12.5 Million Series A Funding for AI Physiotherapy Expansion
Bird & Bird has advised Flok Health on its $12.5 million Series A funding round. Osborne Clarke has advised AlbionVC. Flok Health has completed a $12.5...
9fin’s $50 Million Series B Funding Round
Wilson Sonsini Goodrich & Rosati represented 9fin; Osborne Clarke advised Highland Europe. 9fin, the AI-powered analytics platform for debt capital markets, announced it has raised $50...
Echopoint Medical’s $4.2 Million Series A Funding Round
Osborne Clarke advised AlbionVC on the deal. Echopoint Medical, a cardiovascular diagnostic technology company and a UCL spinout, has secured £4.2 million in Series A funding...
OpenDialog AI’s $13 Million Series A Fundraising Round
Osborne Clarke has advised AlbionVC on investment in OpenDialog AI. OpenDialog AI completed a US$13 million Series A fundraising round. AlbionVC led the investment board, other investors...
FA Bio’s £5.3 Million Investment From Clean Growth Fund, Pymwymic and Ship2B Ventures
Osborne Clarke advised FA Bio on the deal. FA Bio, the British bio-tech company with a vision to protect natural ecosystems by identifying superior microbial bio-products...
StudentCrowd’s Series A Fundraising With Mercia Ventures
Osborne Clarke advised StudentCrowd on Series A fundraising. StudentCrowd, a decision-making platform for higher education, completed its Series A fundraising round led by Mercia Ventures. With...
Bloomsbury Genetic Therapies Limited’s £5 Million Seed Financing
Osborne Clarke advised UCL Technology Fund on the investment. Bloomsbury Genetic Therapies Limited (“Bloomsbury”), a clinical-stage biotechnology company developing potentially curative treatments for patients suffering from...
King’s College London’s Formation of Cytolytix Limited With ValiRx PLC
Osborne Clarke advised King’s College London on the deal. King’s College London established with ValiRx PLC (“ValiRx”) of Cytolytix Limited (“Cytolytix), a new ValiRx subsidiary formed...